Bernadette Connaughton Syneos Health, Inc. (SYNH) insider trading activity

Bernadette Connaughton is Director of Syneos Health, Inc.. Currently has a direct ownership of 0 shares of SYNH, which is worth approximately $0. The most recent transaction as insider was on Sep 28, 2023, when has been sold 14,778 shares (Class A Common Stock) at a price of $21.5 per share, resulting in proceeds of $317,727. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Bernadette Connaughton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 28 2023	SELL Sale (or disposition) back to the issuer	$317,727 $21.5 p/Share	14,778 Reduced 100.0%	0 Class A Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	4,863 Added 24.76%	14,778 Class A Common Stock
May 25 2022	BUY Grant, award, or other acquisition	-	2,839 Added 22.26%	9,915 Class A Common Stock
May 12 2021	BUY Grant, award, or other acquisition	-	2,364 Added 25.04%	7,076 Class A Common Stock
May 27 2020	BUY Grant, award, or other acquisition	$174,991 $62.43 p/Share	2,803 Added 37.3%	4,712 Class A Common Stock
Nov 12 2019	BUY Grant, award, or other acquisition	$94,457 $49.48 p/Share	1,909 Added 50.0%	1,909 Class A Common Stock

Also insider at

HALO

HALOZYME THERAPEUTICS, INC. Healthcare

EDIT

Editas Medicine, Inc. Healthcare

Director